To assess the contributions of Rho/Rac1/Cdc42 signaling in DFX-suppressed cell migration, we analysed the expression of Rho family proteins in DFX-treated pancreatic cancer cell lines using G-LISA. The gene discussed is RHO; the disease is pancreatic neoplasm.